New Reusable Mask Design With Superior Filtration and Fit
Conditions: Covid19; Tuberculosis; Respiratory Viral Infection Interventions: Device: N95 mask; Device: Nordell single E-100 layer mask; Device: Nordell double E-100 layer mask Sponsor: Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2021 Category: Research Source Type: clinical trials
Lipoarabinomannan (LAM) in Urine for Diagnosis of Pulmonary Tuberculosis in HIV Patients
Condition: Role of Urinary LAM in Diagnosis of Active Tuberculosis in Patients With HIV Intervention: Diagnostic Test: Urinary LAM ELISA: Sponsor: Mansoura University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 24, 2021 Category: Research Source Type: clinical trials
Lipoarabinomannan (LAM) in Urine for Diagnosis of Pulmonary Tuberculosis in HIV Patients
Condition: TB - Tuberculosis HIV Intervention: Diagnostic Test: Urinary LAM ELISA: Sponsor: Mansoura University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 24, 2021 Category: Research Source Type: clinical trials
PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis
Conditions: Tuberculosis, Pulmonary; Tuberculosis, Multidrug-Resistant; Bacterial Infections; Mycobacterial Infection Intervention: Diagnostic Test: Individualised treatment duration based on RNA transcriptomic model Sponsors: Research Center Borstel; Ludwig-Maximilians - University of Munich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2021 Category: Research Source Type: clinical trials
Early Risk Assessment in Household Contacts ( ≥10 Years) of TB Patients by New Diagnostic Tests in 3 African Countries
Condition: Tuberculosis Intervention: Diagnostic Test: New test candidates Sponsors: Michael Hoelscher; European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2021 Category: Research Source Type: clinical trials
Early Risk Assessment in Household Contacts ( ≥10 Years) of TB Patients by New Diagnostic Tests in 3 African Countries
Condition: Tuberculosis Intervention: Diagnostic Test: New test candidates Sponsors: Michael Hoelscher; European and Developing Countries Clinical Trials Partnership (EDCTP) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2021 Category: Research Source Type: clinical trials
Early Risk Assessment in Household Contacts ( ≥10 Years) of TB Patients by New Diagnostic Tests in 3 African Countries
Condition: Tuberculosis Intervention: Diagnostic Test: New test candidates Sponsors: Michael Hoelscher; European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2021 Category: Research Source Type: clinical trials
Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers
Condition: Tuberculosis Intervention: Biological: BCG Danish Sponsor: University of Oxford Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2021 Category: Research Source Type: clinical trials
Community intervention for child tuberculosis active contact investigation and management: study protocol for a parallel cluster randomized controlled trial
This study aims to evaluate the impact of a community-based intervention as compared to facility-based model for the management of children in contact with bacteriologically confirmed pulmonary TB adults in low-resource high-burden settings.Methods/designThis multicenter parallel open-label cluster randomized controlled trial is composed of three phases: I, baseline phase in which retrospective data are collected, quality of data recording in facility registers is checked, and expected acceptability and feasibility of the intervention is assessed; II, intervention phase with enrolment of index cases and contact cases in ei...
Source: Trials - March 2, 2021 Category: Research Source Type: clinical trials
Rifampicin at High Dose for Difficult-to-Treat Tuberculosis
Condition: Tuberculosis Intervention: Drug: Rifampin Sponsors: Hospital Universitari Vall d'Hebron Research Institute; University Medical Center Groningen; Radboud University; Centro Hospitalar De São João, E.P.E.; Instituto Nacional de Enfermedades Respiratorias y del Ambiente, Paraguay Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2021 Category: Research Source Type: clinical trials
A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2
Condition: Tuberculosis, Pulmonary Intervention: Drug: Interleukin-2 Sponsor: Beijing Chest Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2021 Category: Research Source Type: clinical trials
